Oragenics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by Oragenics, Inc. on April 5, 2011, regarding events occurring on that date. The Company is incorporated in Florida and is engaged in the biotechnology sector.
Key Financial Metrics
- Debt Drawdown: The Company drew down an additional $500,000 on its existing Credit Facility on April 5, 2011.
- Total Outstanding Debt: Aggregate outstanding balance under the Credit Facility is now $3,500,000.
- Remaining Availability: $1,500,000 remains available under the amended facility.
- Interest Rate: LIBOR plus 6.0%.
- Maturity Date: July 30, 2012.
- Draw Limit: The facility is limited to $500,000 draws per month.
Note: This filing does not provide data on revenue, profit, cash flow, or operating margins.
Material Changes
The primary material change is the execution of a Revolving Unsecured Promissory Note for $500,000 in favor of the Koski Family Limited Partnership (KFLP). This follows a series of amendments to the original Credit Facility established in July 2010:
- January 2011: Facility limit increased from $2.0 million to $2.5 million; $500,000 drawn.
- February 2011: Maturity extended from July 30, 2011, to July 30, 2012; total availability increased by an additional $2.5 million (bringing total facility capacity to $5.0 million).
- March 2011: Previous draw of $500,000.
- April 2011: Current draw of $500,000.
Outlook, Risks, and Management Commentary
The filing indicates the Company is actively utilizing its credit line to fund operations. The extension of the maturity date to July 2012 provides additional time for repayment. The filing does not contain specific forward-looking guidance, risk factors, or management commentary beyond the mechanics of the debt agreement.
Investor Verification Checklist
- Verify the Company's cash burn rate to assess the sustainability of the current $3.5 million debt load.
- Confirm the current LIBOR rate to calculate the precise effective interest cost (LIBOR + 6.0%).
- Review the "conditions precedent" mentioned in the Credit Facility to ensure no covenants have been breached.
- Monitor the $500,000 monthly draw limit to understand future borrowing capacity.
- Check subsequent filings for any further amendments or additional draws against the remaining $1.5 million availability.